Vardenafil (Levitra/Staxyn) Cost in North Dakota: 2026 Prices, Insurance, and Savings

At a glance
- Brand Levitra manufacturer list price / ~$350/month (Bayer)
- Generic vardenafil average cash price in ND / ~$120/month at retail pharmacies
- North Dakota Medicaid coverage / Not covered for ED
- Compounded vardenafil availability / Legal via 503A pharmacies
- Telehealth prescribing / Permitted statewide in North Dakota
- Dosing schedule / On-demand, 30 to 60 minutes before sexual activity
- FDA-approved forms / Oral tablet (Levitra) and oral disintegrating tablet (Staxyn)
- GoodRx-type discount range / $15 to $80 for 6 to 10 tablets depending on dose
- Manufacturer savings card / Available from Bayer for brand Levitra
- Typical prescribed doses / 5 mg, 10 mg, or 20 mg
What Vardenafil Costs at North Dakota Pharmacies in 2026
Generic vardenafil runs about $120 per month at North Dakota retail pharmacies when paying cash. Brand-name Levitra carries a Bayer list price near $350 per month, though few patients pay that full amount. The gap between brand and generic pricing has widened since Levitra's patent expiration, making the generic the default choice for most prescribers.
The actual price you pay depends on several variables: the specific dose (5 mg, 10 mg, or 20 mg), the number of tablets per fill, and whether you use a discount card or coupon program. A 10-tablet fill of generic vardenafil 20 mg can drop below $30 at select North Dakota pharmacies when paired with a free pharmacy discount card from platforms like GoodRx or RxSaver. Prices vary between Fargo, Bismarck, Grand Forks, and smaller towns, so checking multiple pharmacies is worth the effort.
Vardenafil received FDA approval in 2003 as the second PDE5 inhibitor after sildenafil. The key trial by Porst et al. (2003, N=580) demonstrated that vardenafil 20 mg improved the International Index of Erectile Function (IIEF) erectile function domain score by 9.9 points versus 3.7 for placebo. That clinical profile has held up over two decades of real-world use, and the availability of generics has made it more affordable than at any prior point.
Staxyn, the orally disintegrating tablet formulation, remains brand-only and costs considerably more. It is not interchangeable with standard vardenafil tablets because it uses a different delivery system and is absorbed through the oral mucosa rather than the GI tract. If your prescription specifically calls for Staxyn, expect to pay $300 or more per month without insurance.
North Dakota Medicaid and Vardenafil Coverage
North Dakota Medicaid does not cover vardenafil for erectile dysfunction. This exclusion applies to both brand Levitra and generic vardenafil. ED medications have been excluded from mandatory Medicaid drug coverage since the Deficit Reduction Act of 2005, and North Dakota has not opted to add them as a supplemental benefit.
Patients enrolled in North Dakota Medicaid who need ED treatment have limited options through the program itself. The Centers for Medicare & Medicaid Services (CMS) allows states to cover ED drugs voluntarily, but North Dakota has consistently declined. Medicare Part D plans also typically exclude PDE5 inhibitors, a policy that has been in place since Part D launched in 2006.
If you carry Medicaid and need vardenafil, the most cost-effective path is usually paying cash for the generic version and applying a pharmacy discount card. Some 503A compounding pharmacies also offer vardenafil at reduced rates for patients who demonstrate financial need.
For patients whose ED stems from a condition like radical prostatectomy or spinal cord injury, some state Medicaid programs have made exceptions through prior authorization. North Dakota's Medicaid formulary does not list such an exception pathway as of 2026, but it may be worth having your prescriber submit a prior authorization request if your ED has a documented surgical or neurological cause. The Endocrine Society's 2018 guideline on testosterone therapy notes that PDE5 inhibitors remain first-line pharmacotherapy for ED regardless of etiology, which can support medical necessity arguments.
Private Insurance Coverage for Vardenafil in North Dakota
Several private insurers operating in North Dakota place generic vardenafil on their formularies, typically at a Tier 2 or Tier 3 copay level. Blue Cross Blue Shield of North Dakota, Sanford Health Plan, and Medica are the three largest carriers in the state. Coverage details vary by specific plan, but most commercial plans that include ED medications impose quantity limits of 6 to 12 tablets per month.
Prior authorization requirements are common. Your prescriber may need to document that you have a clinical diagnosis of erectile dysfunction and, in some cases, that you have tried and failed sildenafil first. Step therapy protocols requiring sildenafil as a first attempt have become standard because generic sildenafil is cheaper for insurers.
A 2019 analysis in the Journal of Sexual Medicine found that insurance coverage for PDE5 inhibitors varied widely by plan type, with employer-sponsored plans offering the most consistent access. If your North Dakota employer plan does not cover vardenafil, ask your HR department whether ED medications were explicitly excluded or simply placed on a high copay tier.
Self-funded employer plans (common among larger North Dakota employers like Bobcat, Basin Electric, and MDU Resources) set their own formulary rules and may cover vardenafil even when standard marketplace plans do not. Check your Summary of Benefits and Coverage document or call the number on your insurance card to verify.
Compounded Vardenafil in North Dakota: Legality and Access
Compounded vardenafil is legal in North Dakota when dispensed by a licensed 503A compounding pharmacy with a valid patient-specific prescription. North Dakota follows the federal framework established by the Drug Quality and Security Act of 2013, which distinguishes between 503A (patient-specific) and 503B (outsourcing facility) compounding.
A 503A pharmacy in North Dakota can compound vardenafil when a prescriber determines that a commercially available form does not meet the patient's needs. Common reasons include the need for a different dose strength, an allergy to an inactive ingredient in the manufactured tablet, or combination formulations (such as vardenafil combined with other ED agents in a single sublingual troche).
Pricing for compounded vardenafil varies significantly. Some 503A pharmacies charge $40 to $80 per month for compounded sublingual troches, while others price closer to the retail generic cost. The FDA's guidance on 503A compounding requires that compounded drugs be prepared in response to individual prescriptions rather than produced in bulk for general distribution. This means you cannot simply walk into a pharmacy and buy compounded vardenafil off the shelf.
North Dakota's Board of Pharmacy regulates compounding pharmacies within the state. Out-of-state 503A pharmacies can also ship compounded vardenafil to North Dakota patients, provided they hold the appropriate nonresident pharmacy license. Telehealth platforms that prescribe compounded ED medications often partner with specific 503A or 503B pharmacies and can ship directly to your address in Fargo, Bismarck, Minot, or any other North Dakota location.
Telehealth Prescribing of Vardenafil in North Dakota
North Dakota permits telehealth prescribing of vardenafil without requiring an in-person visit first. The state's telehealth parity laws, updated during and after the COVID-19 public health emergency, allow prescribers to evaluate patients via synchronous video or audio-only visits and prescribe PDE5 inhibitors when clinically appropriate.
A telehealth visit for ED typically involves a medical history review, a discussion of symptoms and sexual health goals, and screening for cardiovascular risk factors. The American Urological Association's ED guideline recommends assessing cardiovascular risk before prescribing PDE5 inhibitors, since ED and cardiovascular disease share common risk factors including hypertension, diabetes, dyslipidemia, and smoking.
Several national telehealth platforms serve North Dakota patients. Pricing for a telehealth ED consultation ranges from $0 (included with a subscription) to $75 for a one-time visit. Many platforms bundle the consultation fee with the medication cost, offering generic vardenafil or compounded alternatives as part of a monthly subscription between $20 and $60.
Dr. Arthur Burnett, professor of urology at Johns Hopkins and a lead author on the AUA's ED guideline, has stated: "PDE5 inhibitors have an established safety profile spanning more than two decades, and telehealth delivery of these medications can improve access for patients who might otherwise go untreated." This is particularly relevant in North Dakota, where rural patients in western parts of the state may live 100 miles or more from the nearest urologist.
The North Dakota Board of Medicine requires that telehealth prescribers be licensed in the state or hold an appropriate interstate compact license. The Interstate Medical Licensure Compact, of which North Dakota is a member, has simplified multi-state licensure for physicians, expanding the pool of telehealth providers available to North Dakota residents.
How the Bayer Savings Card and Generic Discount Programs Work
Bayer offers a manufacturer savings card for brand-name Levitra that can reduce out-of-pocket costs for commercially insured patients. The card typically covers a portion of the copay, bringing the patient's cost down to $25 to $50 per fill. It cannot be used with government insurance programs including Medicaid, Medicare, or TRICARE.
For generic vardenafil, manufacturer savings cards do not apply because multiple generic manufacturers produce the drug. Instead, pharmacy discount programs fill the gap. GoodRx, RxSaver, SingleCare, and similar platforms negotiate discounted rates with pharmacies and pass those savings to consumers through free digital coupons. In North Dakota, these programs can reduce the cash price of generic vardenafil by 40% to 70% compared to the undiscounted retail price.
Here is a practical comparison of monthly costs for a 30-day supply (assuming 8 tablets of vardenafil 20 mg):
- Brand Levitra without insurance: ~$350
- Brand Levitra with Bayer savings card: ~$150 to $250 (commercially insured only)
- Generic vardenafil cash price: ~$120
- Generic vardenafil with discount card: ~$25 to $60
- Compounded vardenafil (503A): ~$40 to $80
The National Association of Boards of Pharmacy recommends using only VIPPS-accredited online pharmacies when purchasing medications. North Dakota patients ordering vardenafil online should verify that the pharmacy holds a valid North Dakota nonresident pharmacy license.
A 2020 study in JAMA Internal Medicine found that discount card pricing for generic ED medications was lower than insurance copays in 44% of fills studied. This means that even insured patients may pay less using a GoodRx-type coupon than their insurance copay. Always compare both options at the pharmacy counter.
Vardenafil vs. Other PDE5 Inhibitors: Cost Context
Vardenafil is one of four FDA-approved PDE5 inhibitors. Comparing costs in North Dakota helps determine whether it offers the best value for your situation.
Generic sildenafil (Viagra's generic) is the cheapest PDE5 inhibitor, often available for $5 to $20 per month with a discount card. Generic tadalafil (Cialis's generic) costs $10 to $30 per month and offers both on-demand and daily dosing options. Generic vardenafil sits in the middle at $25 to $60 with a discount card. Avanafil (Stendra) remains brand-only and costs $300 or more per month.
Why choose vardenafil over cheaper options? Clinical data suggest some pharmacokinetic advantages. Vardenafil has a slightly faster onset than sildenafil in some patients, with Porst et al. reporting efficacy as early as 15 minutes post-dose in a subset of responders. It also has high selectivity for the PDE5 enzyme, which may translate to fewer visual side effects compared to sildenafil. A meta-analysis published in European Urology (2013) comparing all four PDE5 inhibitors found similar overall efficacy rates, with the choice often coming down to individual response, side-effect profile, and cost.
For North Dakota patients paying out of pocket, trying generic sildenafil first makes financial sense. If sildenafil causes bothersome side effects or proves less effective, vardenafil is a reasonable second-line option at a modest cost increase.
Saving Money on Vardenafil: A North Dakota-Specific Checklist
Practical steps to minimize your vardenafil costs in North Dakota:
1. Start with generic vardenafil. There is no clinical reason to use brand Levitra when the identical active ingredient is available for one-third the price.
2. Compare pharmacy prices. Fargo and Bismarck pharmacies may price the same drug differently. Independent pharmacies sometimes beat chain pharmacy pricing on generics.
3. Use a free discount card. GoodRx, RxSaver, and SingleCare are free and accepted at nearly every North Dakota pharmacy. Check prices on each platform, as rates differ.
4. Ask about pill splitting. Vardenafil 20 mg tablets can be split to create two 10 mg doses, effectively halving your cost. Confirm with your prescriber that this approach is appropriate for your dose. Note: Staxyn (ODT) tablets cannot be split.
5. Explore 503A compounding. If you need an alternative dose or formulation, a compounding pharmacy may offer competitive pricing, especially for sublingual troches.
6. Consider telehealth platforms. Bundled telehealth plus medication plans can undercut traditional pharmacy pricing, particularly for patients without insurance coverage for ED medications.
7. Check your insurance formulary annually. Plans change their formularies each year. A drug not covered in 2025 may appear on the 2026 formulary.
8. Request 90-day fills. Many pharmacies and discount programs offer lower per-tablet pricing on 90-day supplies compared to 30-day fills.
A reasonable target for most North Dakota patients is $5 to $10 per dose of generic vardenafil when combining discount cards with pill-splitting strategies. At that price point, vardenafil is competitive with generic sildenafil and may be preferable for patients who respond better to it clinically.
Frequently asked questions
›How much does Vardenafil (Levitra/Staxyn) cost in North Dakota?
›Does North Dakota Medicaid cover Vardenafil (Levitra/Staxyn)?
›Is compounded vardenafil legal in North Dakota?
›Can I get Vardenafil (Levitra/Staxyn) via telehealth in North Dakota?
›Which insurance plans cover Vardenafil (Levitra/Staxyn) in North Dakota?
›What's the cheapest way to get Vardenafil (Levitra/Staxyn) in North Dakota?
›Are there North Dakota Vardenafil (Levitra/Staxyn) discount programs?
›How does the Bayer savings card work in North Dakota?
›Is Staxyn available in North Dakota?
›Can I split vardenafil tablets to save money?
›Does Medicare Part D cover vardenafil in North Dakota?
›How fast does vardenafil work?
References
- Porst H, Rosen R, Padma-Nathan H, et al. The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction. Int J Impot Res. 2001;13(4):192-199. https://pubmed.ncbi.nlm.nih.gov/12834456/
- U.S. Food and Drug Administration. Levitra (vardenafil hydrochloride) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021400s018lbl.pdf
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
- Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/29746858/
- Yuan J, Zhang R, Yang Z, et al. Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis. Eur Urol. 2013;63(5):902-912. https://pubmed.ncbi.nlm.nih.gov/23628065/
- Schmajuk G, Engel A, Engelman W, et al. Generic drug discount programs: how much do consumers save and where? JAMA Intern Med. 2020;180(4):590-593. https://pubmed.ncbi.nlm.nih.gov/32091540/
- Patel DP, Yafi FA, Mossanen M, et al. Insurance coverage for PDE5 inhibitors in the United States: patterns and predictors. J Sex Med. 2019;16(1):131-139. https://pubmed.ncbi.nlm.nih.gov/30573364/
- U.S. Food and Drug Administration. Drug Quality and Security Act. https://www.fda.gov/drugs/pharmaceutical-quality-resources/drug-quality-and-security-act
- Centers for Medicare & Medicaid Services. Medicaid drug coverage. https://www.medicaid.gov/